S.G.M. Cloosterman

562 total citations
18 papers, 417 citations indexed

About

S.G.M. Cloosterman is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, S.G.M. Cloosterman has authored 18 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology and Allergy. Recurrent topics in S.G.M. Cloosterman's work include Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (9 papers) and Allergic Rhinitis and Sensitization (9 papers). S.G.M. Cloosterman is often cited by papers focused on Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (9 papers) and Allergic Rhinitis and Sensitization (9 papers). S.G.M. Cloosterman collaborates with scholars based in Netherlands. S.G.M. Cloosterman's co-authors include H. Folgering, C.P. van Schayck, Reinier Akkermans, Constant P. van Schayck, Chris van Weel, Frank J.J. van den Elshout, Lisette van den Bemt, Henk van den Hoogen, Cees L. A. van Herwaarden and C L van Herwaarden and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

S.G.M. Cloosterman

18 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.G.M. Cloosterman Netherlands 13 359 286 98 23 19 18 417
Sears Mr New Zealand 8 182 0.5× 166 0.6× 14 0.1× 37 1.6× 3 0.2× 15 301
B. Boveri Italy 9 345 1.0× 346 1.2× 11 0.1× 4 0.2× 9 0.5× 11 419
Paweł Nastałek Poland 9 173 0.5× 180 0.6× 6 0.1× 6 0.3× 3 0.2× 22 313
Neil MacLennan United Kingdom 4 148 0.4× 21 0.1× 16 0.2× 11 0.5× 17 0.9× 6 258
E.O. Meltzer United States 6 85 0.2× 68 0.2× 52 0.5× 41 1.8× 7 0.4× 12 166
Roopa Trivedi United States 12 588 1.6× 781 2.7× 6 0.1× 30 1.3× 30 901
Á. Callejo Mellén Sweden 7 259 0.7× 248 0.9× 7 0.1× 37 1.6× 15 381
Alireza Eslaminejad Iran 11 66 0.2× 129 0.5× 2 0.0× 14 0.6× 3 0.2× 32 262
Todd M. Adams United Kingdom 2 201 0.6× 273 1.0× 4 0.0× 39 1.7× 1 0.1× 2 332
D Köhler Germany 9 126 0.4× 159 0.6× 2 0.0× 2 0.1× 3 0.2× 33 273

Countries citing papers authored by S.G.M. Cloosterman

Since Specialization
Citations

This map shows the geographic impact of S.G.M. Cloosterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.G.M. Cloosterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.G.M. Cloosterman more than expected).

Fields of papers citing papers by S.G.M. Cloosterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.G.M. Cloosterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.G.M. Cloosterman. The network helps show where S.G.M. Cloosterman may publish in the future.

Co-authorship network of co-authors of S.G.M. Cloosterman

This figure shows the co-authorship network connecting the top 25 collaborators of S.G.M. Cloosterman. A scholar is included among the top collaborators of S.G.M. Cloosterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.G.M. Cloosterman. S.G.M. Cloosterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cloosterman, S.G.M., et al.. (2021). The Potential Impact of Digital Biomarkers in Multiple Sclerosis in The Netherlands: An Early Health Technology Assessment of MS Sherpa. Brain Sciences. 11(10). 1305–1305. 4 indexed citations
2.
Bemt, Lisette van den, S.G.M. Cloosterman, Bart Thoonen, et al.. (2007). Influence of House Dust Mite Impermeable Covers on Health-Related Quality of Life of Adult Patients with Asthma: Results of a Randomized Clinical Trial. Journal of Asthma. 44(10). 843–848. 3 indexed citations
3.
Bemt, Lisette van den, et al.. (2007). House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial.. PubMed. 57(536). 184–90. 26 indexed citations
4.
Bemt, Lisette van den, et al.. (2004). Clinical effectiveness of a mite allergen–impermeable bed-covering system in asthmatic mite-sensitive patients. Journal of Allergy and Clinical Immunology. 114(4). 858–862. 41 indexed citations
5.
Schayck, Constant P. van, et al.. (2002). Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scandinavian Journal of Primary Health Care. 20(2). 126–128. 24 indexed citations
6.
7.
Schayck, C.P. van, et al.. (2002). Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma. European Respiratory Journal. 19(2). 240–245. 15 indexed citations
8.
Schayck, Constant P. van, et al.. (2002). Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scandinavian Journal of Primary Health Care. 20(2). 126–128. 17 indexed citations
9.
Cloosterman, S.G.M., et al.. (2001). Inhaled Corticosteroids, Combined with Long-acting β2-Agonists, Improve the Perception of Bronchoconstriction in Asthma. American Journal of Respiratory and Critical Care Medicine. 164(5). 764–769. 43 indexed citations
10.
Cloosterman, S.G.M., Cees L. A. van Herwaarden, Reinier Akkermans, et al.. (2001). A Placebo-Controlled Clinical Trial of Regular Monotherapy With Short-Acting and Long-Acting β2-Agonists in Allergic Asthmatic Patients. CHEST Journal. 119(5). 1306–1315. 33 indexed citations
11.
Cloosterman, S.G.M., et al.. (2000). Perception of Respiratory Sensation Assessed by Means of Histamine Challenge and Threshold Loading Tests. CHEST Journal. 117(4). 954–959. 24 indexed citations
12.
Cloosterman, S.G.M., et al.. (1999). Relation of the perception of airway obstruction to the severity of asthma. Thorax. 54(1). 15–19. 95 indexed citations
13.
Cloosterman, S.G.M., et al.. (1999). Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients. European Respiratory Journal. 13(5). 955–955. 13 indexed citations
14.
Folgering, H.T.M., et al.. (1999). Perception of bronchoconstriction in asthma patients measured during histamine challenge test. European Respiratory Journal. 14(5). 1049–1054. 25 indexed citations
15.
Cloosterman, S.G.M. & C.P. van Schayck. (1999). House dust mite control measures: effectiveness depends on the severity of asthma?. Data Archiving and Networked Services (DANS). 318. 870–871. 1 indexed citations
16.
Cloosterman, S.G.M., Ingrid Hofland, C.P. van Schayck, & H. Folgering. (1998). Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention. Thorax. 53(9). 768–774. 10 indexed citations
17.
Schayck, C.P. van, et al.. (1995). How Detrimental Is Chronic Use of Bronchodilators in Asthma and Chronic Obstructive Pulmonary Disease?. American Journal of Respiratory and Critical Care Medicine. 151(5). 1317–1319. 19 indexed citations
18.
Cloosterman, S.G.M., et al.. (1995). Long-term effects of mattress-covers on house dust mite (Der-p-1). Radboud Repository (Radboud University). 8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sears Mr Breakdown of academic impact, for papers by B. Boveri Breakdown of academic impact, for papers by Paweł Nastałek Breakdown of academic impact, for papers by Neil MacLennan Breakdown of academic impact, for papers by E.O. Meltzer Breakdown of academic impact, for papers by Roopa Trivedi Breakdown of academic impact, for papers by Á. Callejo Mellén Breakdown of academic impact, for papers by Alireza Eslaminejad Breakdown of academic impact, for papers by Todd M. Adams Breakdown of academic impact, for papers by D Köhler
Rankless by CCL
2026